Close

Aurinia Pharmaceuticals's (AUPH) Outperform Rating Reiterated at FBR Following AURA-LV Phase IIb Data

Go back to Aurinia Pharmaceuticals's (AUPH) Outperform Rating Reiterated at FBR Following AURA-LV Phase IIb Data
(NASDAQ: AUPH) Delayed: 4.81 -0.1 (2.04%)
Previous Close $4.91    52 Week High $5.69 
Open $4.91    52 Week Low $1.42 
Day High $4.96    P/E N/A 
Day Low $4.71    EPS $0.00 
Volume 2,097,931